CLOSE ✕
Get in Touch
Thank you for your interest! Please fill out the form below if you would like to work together.

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form

BLOG

Dual Gene Therapy Has Beneficial Effects On Blood Biomarkers And Muscle Composition

Biomarker analysis and MRI imaging data from the past year have revealed beneficial metabolic changes and muscle improvement in Elizabeth Parrish, CEO of BioViva USA Inc. and recipient of BioViva’s experimental dual gene therapy in September 2015.

READ MORE

One Year Anniversary of BioViva's Gene Therapy Against Human Aging

An open letter by the CEO of BioViva, Elizabeth Parrish, on the first anniversary of BioViva’s gene therapy against aging. One year ago today Elizabeth became the first person in the world to undergo a dual gene therapy treatment, specifically designed to treat biological aging.

READ MORE

Gene Therapy for Sickle Cell Disease Passes Key Preclinical Test

September

Decades-old discovery about fetal hemoglobin may soon be cured using gene therapy. The clinical trial set to take place in the coming year

READ MORE

BIOVIVA, GENE THERAPY AND BLOCKCHAIN MERGES IN RUSSIA

On the 20th of June, Elizabeth Parrish visited Moscow. As a result of the meeting an announcement was made with BioViva to open an outreach office in Russia. Additionally, an agreement to implement a crowd investing campaign for BioViva

READ MORE

FIRST PATENT APPLICATION FOR DUAL GENE THERAPY TARGETING THE AGING PROCESS

June 17, 2016

BioViva USA Inc. files for patent for dual gene therapy to restore telomere attrition and muscle degradation caused by aging.

READ MORE

BIOVIVA TALKS AT THE 2B AHEAD THINKTANK FUTURE CONGRESS IN GERMANY

June 18, 2016

This year, the 15th annual 2b AHEAD ThinkTank Future Congress 2016 was held on June 14-15, 2016 at Wolfsburg Castle, in Hannover.

READ MORE

FIRST GENE THERAPY SUCCESSFUL AGAINST HUMAN AGING

April 21, 2016

American woman gets biologically younger after gene therapies

READ MORE

DEEP KNOWLEDGE LIFE SCIENCES AND BIOVIVA ANNOUNCE PARTNERSHIP

April 19, 2016

Seattle-based biotech startup BioViva USA Inc. and London-based biotech investment fund Deep Knowledge Life Sciences (DKLS) are announcing a partnership with the aim of bringing about affordable gene therapies.

READ MORE

ALZHEIMER’S CURE

October 07, 2015

How Alzheimer’s Can Be Prevented and Cured…

READ MORE

BIOVIVA AND TELOCYTE

October 02, 2015

BioViva will be using FDA standards and an IRB in all of our clinical trials.

READ MORE

THE TELOMERES-P53-PGC AGING AXIS

August 27, 2015

This 2011 paper by Dr DePinho builds on previous papers and his theory of the “telomere-p53-PGC axis”.

READ MORE

GENE THERAPY IS THE FUTURE

August 15, 2015

BioViva – Gene Therapy to Treat AgingWritten by Sven Bulterijs, & Avi Roy

READ MORE

SOCIAL